Intuitive Surgical (NASDAQ:ISRG) was upgraded by stock analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Wednesday.
Several other equities analysts have also weighed in on the stock. Zacks Investment Research raised shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating and set a $437.00 target price for the company in a report on Tuesday, December 12th. ValuEngine lowered shares of Intuitive Surgical from a “hold” rating to a “sell” rating in a report on Friday, December 29th. Goldman Sachs Group reaffirmed a “buy” rating on shares of Intuitive Surgical in a report on Saturday, November 18th. Morgan Stanley lifted their target price on shares of Intuitive Surgical from $450.00 to $500.00 and gave the company an “overweight” rating in a report on Friday, January 26th. Finally, Vetr raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $434.75 target price for the company in a report on Monday, January 8th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $408.48.
Intuitive Surgical (ISRG) opened at $419.79 on Wednesday. Intuitive Surgical has a 1 year low of $242.26 and a 1 year high of $452.00. The stock has a market cap of $46,779.06, a P/E ratio of 73.91, a price-to-earnings-growth ratio of 4.96 and a beta of 0.50.
Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, January 25th. The medical equipment provider reported $2.54 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.27 by $0.27. Intuitive Surgical had a net margin of 21.09% and a return on equity of 19.93%. The company had revenue of $892.40 million during the quarter, compared to analyst estimates of $866.54 million. During the same period last year, the firm posted $2.03 EPS. Intuitive Surgical’s revenue for the quarter was up 17.9% compared to the same quarter last year. analysts anticipate that Intuitive Surgical will post 7.85 EPS for the current year.
In related news, COO Salvatore Brogna sold 6,082 shares of Intuitive Surgical stock in a transaction on Friday, December 1st. The shares were sold at an average price of $397.61, for a total value of $2,418,264.02. Following the sale, the chief operating officer now owns 3,096 shares of the company’s stock, valued at approximately $1,231,000.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Jamie Samath sold 861 shares of Intuitive Surgical stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $420.09, for a total transaction of $361,697.49. Following the completion of the sale, the vice president now directly owns 1,232 shares in the company, valued at approximately $517,550.88. The disclosure for this sale can be found here. Insiders sold a total of 85,877 shares of company stock worth $35,631,764 in the last three months. 2.20% of the stock is owned by corporate insiders.
A number of institutional investors have recently added to or reduced their stakes in the stock. Cambridge Investment Research Advisors Inc. grew its stake in Intuitive Surgical by 220.2% in the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 3,765 shares of the medical equipment provider’s stock valued at $1,374,000 after acquiring an additional 2,589 shares during the period. KCM Investment Advisors LLC acquired a new stake in Intuitive Surgical in the 4th quarter valued at $290,000. Albion Financial Group UT grew its stake in Intuitive Surgical by 200.0% in the 4th quarter. Albion Financial Group UT now owns 1,005 shares of the medical equipment provider’s stock valued at $367,000 after acquiring an additional 670 shares during the period. Xact Kapitalforvaltning AB grew its stake in Intuitive Surgical by 220.4% in the 4th quarter. Xact Kapitalforvaltning AB now owns 20,823 shares of the medical equipment provider’s stock valued at $7,599,000 after acquiring an additional 14,323 shares during the period. Finally, Envestnet Asset Management Inc. grew its stake in Intuitive Surgical by 157.7% in the 4th quarter. Envestnet Asset Management Inc. now owns 43,284 shares of the medical equipment provider’s stock valued at $15,794,000 after acquiring an additional 26,489 shares during the period. 61.59% of the stock is currently owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY NOTICE: This piece was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this piece can be read at https://www.dispatchtribunal.com/2018/02/23/intuitive-surgical-isrg-raised-to-strong-buy-at-bidaskclub.html.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.